Intravesical Delivery of Small Activating RNA Formulated Into Lipid Nanoparticles Inhibits Orthotopic Bladder Tumor Growth

Cancer Research - United States
doi 10.1158/0008-5472.can-12-1871
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Efficacy of Intravesical Bacillus Calmette-Guérin Therapy Against Tumor Immune Escape in an Orthotopic Model of Bladder Cancer

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

Targeted, Systemic Delivery of Therapeutic Small Interfering RNA Nanoparticles

Science-Business eXchange
2009English

RNA Interference Against Hec1 Inhibits Tumor Growth in Vivo

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2005English

Small Interfering RNA Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis

Cancer Research
Cancer ResearchOncology
2007English

Targeting RNA Polymerase I With an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth

Cancer Research
Cancer ResearchOncology
2010English

Tumor-Specific Delivery of KRAS siRNA With iRGD-exosomes Efficiently Inhibits Tumor Growth

ExRNA
2019English

Delivery of Therapeutic Small Interfering RNA to Tumor-Associated Immune Cells

Science-Business eXchange
2009English

283. Targeted Delivery of C/EBPα-Small Activation RNA (saRNA) by RNA Aptamer Inhibits the Growth of Pancreatic Ductal Adenocarcinoma (PDAC) in Vivo

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Corrigendum to “Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-Specific RNA Aptamers Inhibits Tumor Growth in Vivo”

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy